CSPC Pharmaceutical Group (HKSE:01093) Land And Improvements : HK$0 Mil (As of Jun. 2024)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Land And Improvements?

CSPC Pharmaceutical Group's land and improvements for the quarter that ended in Jun. 2024 was HK$0 Mil.

CSPC Pharmaceutical Group Land And Improvements Historical Data

The historical data trend for CSPC Pharmaceutical Group's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Land And Improvements Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

CSPC Pharmaceutical Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Land And Improvements	Get a 7-Day Free Trial															-	-	-	-	-

CSPC Pharmaceutical Group Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Cai Dong Chen	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Blackrock, Inc.	2201 Interest of corporation controlled by you
True Ally Holdings Limited	2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si	2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si	2101 Beneficial owner

CSPC Pharmaceutical Group Headlines

No Headlines